Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone for Late-Life Depression
NCT07623135Phase 3Recruiting
- Start
- Sep 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 3 trial of lumateperone in treatment-resistant depression (TRD). Started Sep 2026; status: recruiting.
02
Drugs
lumateperone
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07623135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07623135.